Tel +27 (021) 880 1444 | Fax +27 (021) 880 0291 | P.O. Box 12602, Die Boord, Stellenbosch, 7613
Back in 2001 a major study claimed that giving adolescents antidepressants was both effective and not harmful. In 2012 GSK, the makers of paroxetine, an SSRI, pleaded guilty to cases of fraud about this and other drugs and were fined 3 billion. Part of the settlement forced them to put their drug trial data online. This allowed scientists to re-analyse this trial’s data. The re-analysis has just been published in the British Medical Journal and concludes exactly the opposite – ‘Neither paroxetine nor high-dose imipramine demonstrated efficacy for major depression in adolescents, and there was an increase in harms with both drugs.’ Thousands of adolescents have been harmed, and some have died because of the drug company misleading people.
A new clinical trial is shedding light on turmeric’s remarkable liver protective and regenerative properties. A fermented form of turmeric powder (2 X 3 g capsules three times a day) was shown to reduce the markers for liver damage (alanine aminotransferase).
Now researchers have the first evidence (published in the Journal of the American Heart Association) that eating too much sugar over the course of many years dramatically increases the risk of developing and dying from heart failure.
According to a study out of Cambridge, England, the more we eat for breakfast versus other meals, the less likely we are to gain weight. Over four years, those who ate 11% or less of their daily calories at breakfast gained up to one pound more than those who ate 22 to 50%.
Unpublished preliminary clinical data on maitake’s use as an adjunct to chemotherapy were reported in 1997. A non-randomised clinical study was conducted with a total of 165 cancer patients in stage III and IV, from 25 to 65 years old. Patients were administered chemotherapy or were given tablets containing maitake together with chemotherapy. According to Dr Nanba, ‘The results suggest that breast, lung and liver cancers were improved by maitake, but it was less effective against bone and stomach cancers or leukemia.’ The best response rates were from combining maitake and chemotherapy. Most of the patients under the maitake treatment claimed improvement of overall symptoms, even when tumour regression was not observed. Some of the chemotherapy side effects, such as lost appetite, vomiting, nausea, hair loss and pain, were reduced.
Page 7 of 9
Click here to browse or order previous issues